Stocks
Intra-Cellular Therapies (ITCI) P/S US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/S | ? | 31 238 | 99.3 | 52.0 | 20.0 | 14.9 | 9.90 | ||
| Changes by years, y/y, % | -100% | -48% | -62% | -26% | -85.2% | ||||
Intra-Cellular Therapies. P/S
Intra-Cellular Therapies. P/S, changes, %
Intra-Cellular Therapies (ITCI) P/S US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| P/S | ? | 16.7 | 16.7 | 12.0 | 14.9 | 13.1 | 9.90 | |
| Changes by years, y/y, % | -70% | -58% | -49% | -26% | -21% | |||
| Changes by quarters, q/q, % | -17% | +0% | -28% | +25% | -12% | |||
